HEMOCO: a French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1). 1996

F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
Unité INSERM U-292, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.

HEMOCO is a multicenter prospective cohort set up in 1989 to monitor 407 French hemophiliacs infected by HIV-1 and recruited in 4 hemophilia treatment centers in the Paris region. As of 15 July 1995, 42% of the patients in the cohort had developed stage B HIV disease and 29% stage C disease (AIDS); 23.1% of the patients had died. The cumulative proportion of patients with AIDS was 4.5% at 5 years and 27.4% at 10 years, while the respective mortality rates were 3.8% and 19.5%. In our study, only age was predictive of AIDS, with an estimated relative risk of 1.2 per 10-year age increment; this factor was also predictive of death. After 10 years of follow-up, 6.1% of the study population had no clinical or laboratory signs of immunodepression. The follow-up protocol in the HEMOCO protocol is the same as that in the French SEROCO study, which includes men infected by HIV-1 through sexual contact. This will allow us to compare the progression of HIV infection between these two exposure groups.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
June 1994, The Pediatric infectious disease journal,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
June 2019, Pharmaceutics,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
January 1988, Transfusion,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
January 1994, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
May 2000, The Journal of infectious diseases,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
September 1999, The Journal of infectious diseases,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
September 2013, Journal of virology,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
November 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
August 1995, The Journal of arthroplasty,
F Boufassa, and N Carré, and C Deveau, and Y Sultan, and C Gazengel, and A Blanc, and J Peynet, and D Ramirez, and L Meyer
June 1989, The New England journal of medicine,
Copied contents to your clipboard!